Histamine modulates γδ-T lymphocyte migration and cytotoxicity, via G i and G s protein-coupled signalling pathways

British Journal of Pharmacology

Volumn 161, Issue 6, 2010, Pages 1291-1300

  Truta Feles, K ^a,b   Lagadari, M ^a   Lehmann, K ^a   Berod, L ^a   Cubillos, S ^a   Piehler, S ^a   Herouy, Y ^a   Barz, D ^a   Kamradt, T ^a   Maghazachi, A ^c   Norgauer, J ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b HANS KNÖLL INSTITUTE   (Germany)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

T lymphocytes; Cytotoxicity; G protein; Histamine; Migration

Indexed keywords

6 [2 (4 IMIDAZOLYL)ETHYLAMINO] N 4 TRIFLUOROMETHYLPHENYLHEPTANECARBOXAMIDE DIMALEATE; ACTIN; AMIDE; CHOLERA TOXIN; CIMETIDINE; CLOBENPROPIT; DIMAPRIT; HISTAMINE H2 RECEPTOR; HISTAMINE H2 RECEPTOR AGONIST; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTAGONIST; HISTAMINE RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; PERTUSSIS TOXIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TRIPROLIDINE; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ARTICLE; BURKITT LYMPHOMA; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CANCER CELL CULTURE; CELL INTERACTION; CELL ISOLATION; CELL MIGRATION; CELL STRAIN K 562; CHEMOTAXIS; CHOLERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ERYTHROLEUKEMIA; GENE EXPRESSION; HISTAMINE RELEASE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOSURVEILLANCE; LEUKEMIA CELL; LEUKEMIA CELL LINE; LYMPHOBLASTOMA; LYMPHOMA CELL LINE; MELANOMA CELL; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PERTUSSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAJI CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR CELL LINE; WESTERN BLOTTING;

CELL MOVEMENT; CYTOTOXICITY, IMMUNOLOGIC; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HISTAMINE; HUMANS; JURKAT CELLS; K562 CELLS; LEUKOCYTES, MONONUCLEAR; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, HISTAMINE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 78049390719     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00639.x     Document Type: Article

References (53)

1. Aichberger KJ, Mayerhofer M, Vales A, Krauth MT, Gleixner KV, Bilban M etal. (2006). The CML-related oncoprotein BCR/ABL induces expression of histidine decarboxylase (HDC) and the synthesis of histamine in leukemic cells. Blood 108: 3538-3547.
2. Akdis CA, Simons FER (2006). Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 533: 69-76.
3. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2): S1-S209.
4. Argentati K, Re F, Serresi S, Tucci MG, Bartozzi B, Bernardini G et al. (2003). Reduced number and impaired function of circulating gdT cells in patients with cutaneous primary melanoma. J Invest Dermatol 120: 829-834.
5. Arrange JM, Garbarg M, Schwartz JC (1983). Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302: 832-837.
6. Baker JG (2008). A study of antagonist affinities for the human histamine H2 receptor. Br J Pharmacol 153: 1011-1021.
7. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
8. Berridge MJ, Imine RF (1989). Inositol phosphates and cell signalling. Nature 341: 197.
9. Boullier S, Poquet Y, Debord T, Fournie J, Gougeon M (1999). Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vg9Vd2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected person. Eur J Immunol 29: 90-99.
10. Brenner MB, McLean J, Dialynas DP, Strominger JL, Smith JA, Owen FL et al. (1986). Identification of putative second T-cell receptor. Nature 322: 145.
11. Brimble MJ, Wallis DI (1973). Histamine H1 and H2-receptors at a ganglionic synapse. Nature 246: 156-158.
12. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB et al. (1995). V gamma 2V delta 2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 154: 998-1006.
13. Camps M, Carozzi A, Schnabel P, Scheer P, Parker PJ, Gierschik P (1992). Isozyme-selective stimulation of phospholipase C-beta by G-protein beta-gamma subunits. Nature 360: 684-686.
14. Chen Z (2002). Comparative biology of γδ T cells. Science Pogress 85: 347-358.
15. Dale HH, Laidlaw PP (1910). The physiological action of b-imidazolethylamine. J Physiol 41: 318-344.
16. Damaj BB, Becerra CB, Esber HJ, Wen Y, Maghazachi AA (2007). Functional expression of H4 histamine receptor in human natural killer cells, monocytes, and dendritic cells. J Immunol 179: 7907-7915.
17. Drutel G, Peitsaro N, Karlstedt K, Wieland K, Smit MJ, Timmerman H et al. (2001). Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol Pharmacol 59: 1-8.
18. + T cells. J Immunol 176: 7062-7070.
19. Feske S (2007). Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol 7: 690-702.
20. Girardi M (2006). Immunosurveillance and immunoregulation by γδ T cells. J Investigative Dermatol 126: 25-31.
21. Gutzmer R, Diestel C, Mommert S, Kother B, Stark H, Wittmann M et al. (2005). Histamine H4 receptor stimulation suppresses IL-12p70 production and mediates chemotaxis in human monocyte-derived dendritic cells. J Immunol 174: 5224-5232.
22. Haas W, Pereira P, Tonegawa S (1993). Gamma/delta T cells. Annu Rev Immunol 11: 637-685.
23. Haas HL, Sergeeva OA, Selbach O (2008). Histamine in the Nervous System. Physiol Rev 88: 1183-1241.
24. Hauert AB, Martinelli S, Marone C, Niggli V (2002). Differentiated HL-60 cells are a valid model system for the analysis of human neutrophil migration and chemotaxis. Int J Biochem Cell Biol 34: 838-854.
25. Hegyesi H, Tóth S, Molnár V, Fülöp KA, Falus A (2008). Endogenous and exogenous histamine influences on angiogenesis related gene expression of mice mammary adenocarcinoma. Inflamm Res 56: 37-38.
26. Herberman RB (1981). Natural killer (NK) cells and their possible roles in resistance against disease. Clin Immunol Rev 1: 1-65.
27. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM et al. (1997). International union of pharmacology. XIII. Classification of histamine receptors. Pharmacological Rev 49: 253-278.
28. 4 receptor mediates chemotaxis and calcium mobilization of mast cells. JPET 305: 1212-1221.
29. Idzko M, La Sala A, Ferrari D, Panther E, Herouy Y, Dichmann S et al. (2002). Expression and function of histamine receptors in human monocyte derived dendritic cells. J Allergy Clin Immunol 109: 839-846.
30. Kabelitz D (1993). Human γδ T cells. Int Arch Allergy Immunology 102: 1-9.
31. Kabelitz D, Glatzel A, Wesch D (2000). Antigen recognition by human γδ T lymphocytes. Int Arch Allergy Immunol 122: 1-7.
32. Kinet JP (1999). The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17: 931-972.
33. s protein-mediated signaling. Int Immunol 21: 667-677.
34. Lazar-Molnar E, Hegyesi H, Toth S, Darvas ZS, Laszlo V, Szalai CS et al. (2000). Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine. Blood 10: 25-28.
35. 4 receptor. Br J Pharmacol 157: 14-23.
36. 2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kB/NF-kB signal cascades. Biochem Pharmacol 69: 433-449.
37. Matsuki Y, Tanimoto A, Hamada T, Sasaguri Y (2003). Histidine decarboxylase expression as a new sensitive and specific marker for small cell lung carcinoma. Mod Pathol 16: 72-78.
38. Nakata M, Smyth MJ, Norihisa Y, Kawasaki A, Shinkai Y, Okumura K et al. (1990). Constitutive expression of pore-forming protein in peripheral blood γδ T cells: implication for their cytotoxic role in vivo. J Exp Med 172: 1877-1880.
39. Ohtsu H (2008). Progress in allergy signal research on mast cells: the role of histamine in immunological and cardiovascular disease and the transporting system of histamine in the cell. J Pharmacol Sci 106: 347-353.
40. Panther E, Idzko M, Herouy Y, Rheinen H, Gebicke-Haerter PJ, Mrowietz U et al. (2001). Expression and function of adenosine receptors in human dendritic cells. FASEBJ 15: 1963-1970.
41. Pepe S, Ruggiero A, Tortora G, Ciardiello F, Garbi C, Yokozaki H et al. (1994). Flow-cytometric detection of the RI alpha subunit of type I cAMP-dependent protein kinase in human cells. Cytometry 15: 73-79.
42. Riley JF, West GB (1952). Histamine in tissue mast cells. J Physiol 117: 72-73.
43. Rosenberg SA (2001). Progress in human tumour immunology and immunotherapy. Nature 411: 380-384.
44. Selin LK, Santolucito PA, Pinto AK, Szomolanyi-Tsuda E, Welsh RM (2001). Innate immunity to viruses: control of vaccinia virus infection by γδ T cells. J Immunol 166: 6784-6794.
45. Sicard H, Saati TA, Delsol G, Fournier JJ (2001). Synthetic phosphoantigens enhance human Vg9Vd2 T lymphocytes killing of non-Hodgkin's B lymphoma. Mol Medicine 7: 711-722.
46. Sonobe Y, Nakane H, Watanabe T, Nakano K (2004). Regulation of Con A-dependent cytokine production from CD4+ and CD8+ T lymphocytes by autosecretion of histamine. Inflamm Res 53: 87-92.
47. Stossel TP (1989). From signal to pseudopod. J Biol Chem 264: 18261.
48. Sugawara S, Kaslow HR, Dennert G (1993). CTX-B inhibits CTL cytotoxicity and cytoskeletal movements. Immunopharmacology 26: 93-104.
49. Tranquillo RT, Lauffenburger DA, Zigmond SH (1988). A stochastic model for leukocyte random motility and chemotaxis based on receptor binding fluctuations. J Cell Biol 106: 303-309.
50. Wang X, Fiscus RR, Yang L, Mathews HL (1995). Suppression of the functional activity of IL-2-activated lymphocytes by CGRP. Cell Immunol 162: 105-113.
51. Wrobel P, Shijaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H et al. (2007). Lysis of a broad range of epithelial tumor cells by human γδ T cells: Involvement of NKG2D ligands and T-cell receptor-versus NKG2D-dependent recognition. Scand J Immunol 66: 320-328.
52. Yakabi K, Kawashima J, Kato S (2008). Ghrelin and gastric acid secretion. World J Gastroenterol 14: 6334-6338.
53. 4 receptor in immune and inflammatory disorders. Br J Pharmacol 157: 24-33.